Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer

Summary

Actinium Pharmaceuticals appointed Matt David, M.D. as Chief Financial Officer. The appointment represents a routine management change at the targeted radiotherapy company.